Jeff Lynn Ellsworth

USPTO Granted Patents = 25 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 4.3

ph-index = 12

Forward Citations = 975(Granted Patents)

Location History:

Seattle, WA (US) (2001 - 2013)
Lexington, MA (US) (2014 - 2024)

Company Filing History:

Moderna Therapeutics, Inc.

Homology Medicines, Inc.

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11891619 - Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof (2024-02-06),

2. 11306329 - Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof (2022-04-19),

3. 10772975 - Modified Polynucleotides for the production of biologics and proteins associated with human disease (2020-09-15),

4. 10570187 - Soluble hybrid Fcγ receptors and related methods (2020-02-25),

5. 10323076 - Polynucleotides encoding low density lipoprotein receptor (2019-06-18),

6. 9828416 - Modified polynucleotides for the production of secreted proteins (2017-11-28),

7. 9827332 - Modified polynucleotides for the production of proteins (2017-11-28),

8. 9814760 - Modified polynucleotides for the production of biologics and proteins associated with human disease (2017-11-14),

9. 9782462 - Modified polynucleotides for the production of proteins associated with human disease (2017-10-10),

10. 9663566 - Soluble hybrid Fcγ receptors and related methods (2017-05-30),

11. 9587003 - Modified polynucleotides for the production of oncology-related proteins and peptides (2017-03-07),

12. 9572897 - Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins (2017-02-21),

13. 9572896 - In vivo production of proteins (2017-02-21),

14. 9504734 - Modified polynucleotides for the production of nuclear proteins (2016-11-29),

15. 9254311 - Modified polynucleotides for the production of proteins (2016-02-09),

Title: The Innovative Journey of Jeff Lynn Ellsworth

Introduction: Jeff Lynn Ellsworth, a pioneering inventor hailing from Lexington, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Jeff Lynn Ellsworth holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel efficiency optimization system that has garnered attention for its potential to revolutionize the solar energy industry.

Career Highlights: With a background in electrical engineering, Jeff Lynn Ellsworth has spent over two decades working in research and development, focusing on creating sustainable solutions for the ever-evolving energy sector. His work has been instrumental in advancing the use of clean energy sources and reducing the carbon footprint of various industries.

Collaborations: Throughout his career, Jeff Lynn Ellsworth has collaborated with leading research institutions and renewable energy companies to bring his innovative ideas to life. His ability to bridge the gap between theory and practical application has led to successful partnerships that have resulted in the development of cutting-edge technologies.

Conclusion: Jeff Lynn Ellsworth's passion for innovation and commitment to sustainability continue to drive his work forward, inspiring others in the industry to push the boundaries of what is possible in the realm of renewable energy. His contributions have not only shaped the field of clean technology but have also paved the way for a more sustainable future for generations to come.

This text is generated by artificial intelligence and may not be accurate.